{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:11:30Z","timestamp":1787505090190,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glaucomatous optic neuropathy (GON) is an anatomofunctional impairment of the optic nerve triggered by glaucoma. Recently, growth factors (GFs) have been shown to produce retinal neuroenhancement. The suprachoroidal autograft of mesenchymal stem cells (MSCs) by the Limoli retinal restoration technique (LRRT) has proven to achieve retinal neuroenhancement by producing GF directly into the choroidal space. This retrospectively registered clinical study investigated the visual function changes in patients with GON treated with LRRT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty-five patients (35 eyes) with GON in progressive disease conditions were included in the study. Each patient underwent a comprehensive ocular examination, including the analysis of best corrected visual acuity (BCVA) for far and near visus, sensitivity by Maia microperimetry, and the study of the spectral domain-optical coherence tomography (SD-OCT). The patients were divided into two groups: a control group, consisting of 21 eyes (average age 72.2 years, range 50\u201383), and an LRRT group, consisting of 14 eyes (average age 67.4, range 50\u201384).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After 6 months, the BCVA, close-up visus, and microperimetric sensitivity significantly improved in the LRRT-treated group (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.05), whereas the mean increases were not statistically significant in controls (\n                      <jats:italic>p<\/jats:italic>\n                      &gt;0.5).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with GON treated with LRRT showed a significant increase in visual performance (VP) both in BCVA and sensitivity and an improvement of residual close-up visus, in the comparison between the LRRT results and the control group. Further studies will be needed to establish the actual significance of the reported findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-021-02351-4","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T06:03:39Z","timestamp":1620281019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mesenchymal stem and non-stem cell surgery, rescue, and regeneration in glaucomatous optic neuropathy"],"prefix":"10.1186","volume":"12","author":[{"given":"Paolo Giuseppe","family":"Limoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Limoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo Maria","family":"Vingolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Franzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5512-0849","authenticated-orcid":false,"given":"Marcella","family":"Nebbioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"2351_CR1","doi-asserted-by":"publisher","unstructured":"Tham YC Li X Wong TY Quigley HA Aung T Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081\u201390. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013.","DOI":"10.1016\/j.ophtha.2014.05.013"},{"key":"2351_CR2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.preteyeres.2012.07.001","volume":"6","author":"DJ Calkins","year":"2012","unstructured":"Calkins DJ. Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog. Retin. Eye Res. 2012;6:702\u201319.","journal-title":"Prog. Retin. Eye Res."},{"issue":"5","key":"2351_CR3","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.ophtha.2011.11.003","volume":"119","author":"EE Chang","year":"2012","unstructured":"Chang EE, Goldberg JL. Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology. 2012;119(5):979\u201386. https:\/\/doi.org\/10.1016\/j.ophtha.2011.11.003.","journal-title":"Ophthalmology."},{"key":"2351_CR4","unstructured":"Chua J Vania M Cheung CM Ang M Chee SP Yang H et al. Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes. Mol. Vis. 2012;18:431\u20138."},{"issue":"8","key":"2351_CR5","doi-asserted-by":"publisher","first-page":"a017269","DOI":"10.1101\/cshperspect.a017269","volume":"4","author":"I Soto","year":"2014","unstructured":"Soto I Howell GR. The complex role of neuroinflammation in glaucoma. Cold Spring Harb. Perspect. Med. 2014;4(8):a017269. https:\/\/doi.org\/10.1101\/cshperspect.a017269.","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2351_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.exer.2017.01.007","volume":"157","author":"DJ Calkins","year":"2017","unstructured":"Calkins DJ. The challenge of regenerative therapies for the optic nerve in glaucoma. Exp. Eye Res. 2017;157:28\u201333. https:\/\/doi.org\/10.1016\/j.exer.2017.01.007.","journal-title":"Exp. Eye Res."},{"key":"2351_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.01.004","volume":"58","author":"MK Jones","year":"2017","unstructured":"Jones MK Lu B, Girman S Wang S. Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases. Prog. Retin. Eye Res. 2017;58:1\u201327. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.01.004.","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"2351_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/stem.2722","volume":"36","author":"A Osborne","year":"2018","unstructured":"Osborne A, Sanderson J, Martin KR. Neuroprotective effects of human mesenchymal stem cells and platelet-derived growth factor on human retinal ganglion cells. Stem Cells. 2018;36(1):65\u201378. https:\/\/doi.org\/10.1002\/stem.2722.","journal-title":"Stem Cells."},{"key":"2351_CR9","volume":"132","author":"PG Limoli","year":"2018","unstructured":"Limoli PG Limoli C Vingolo EM, Limoli C Scalinci SZ Nebbioso M. Regenerative therapy by suprachoroidal cell autograft in dry age-related macular degeneration: preliminary in vivo report. J. Vis. Exp. 2018;132:e56469.","journal-title":"J. Vis. Exp."},{"issue":"94","key":"2351_CR10","first-page":"30","volume":"7","author":"PG Limoli","year":"2019","unstructured":"Limoli PG, Vingolo EM, Limoli C, Nebbioso M. Stem cell surgery and growth factors in retinitis pigmentosa patients: pilot study after literature review. Biomedicines. 2019;7(94):30.","journal-title":"Biomedicines"},{"issue":"30","key":"2351_CR11","doi-asserted-by":"publisher","first-page":"46913","DOI":"10.18632\/oncotarget.10442","volume":"7","author":"PG Limoli","year":"2016","unstructured":"Limoli PG, Limoli C, Vingolo EM, Scalinci SZ, Nebbioso M. Cell surgery and growth factors in dry age-related macular degeneration: visual prognosis and morphological study. Oncotarget. 2016;7(30):46913\u201323. https:\/\/doi.org\/10.18632\/oncotarget.10442.","journal-title":"Oncotarget."},{"issue":"3","key":"2351_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3233\/RNN-190970","volume":"38","author":"PG Limoli","year":"2020","unstructured":"Limoli PG Limoli CSS Morales MU, Vingolo EM. Mesenchymal stem cell surgery, rescue and regeneration in retinitis pigmentosa: clinical and rehabilitative prognostic aspects. Restor. Neurol. Neurosci. 2020;38(3):223\u201337. https:\/\/doi.org\/10.3233\/RNN-190970.","journal-title":"Restor. Neurol. Neurosci."},{"issue":"12","key":"2351_CR13","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1007\/s10792-019-01141-5","volume":"39","author":"A Oner","year":"2019","unstructured":"Oner A Gonen ZB Sevim DG Sinim Kahraman N Unlu M. Six-month results of suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with optic atrophy: a phase 1\/2 study. Int. Ophthalmol. 2019;39(12):2913\u201322. https:\/\/doi.org\/10.1007\/s10792-019-01141-5.","journal-title":"Int. Ophthalmol."},{"key":"2351_CR14","doi-asserted-by":"publisher","unstructured":"Lawrence N Coleman WP 3rd. Liposuction. J Am. Acad. Dermatol. 2002;47(1):105\u20138. https:\/\/doi.org\/10.1067\/mjd.2002.122189.","DOI":"10.1067\/mjd.2002.122189"},{"key":"2351_CR15","doi-asserted-by":"publisher","unstructured":"Yoshimura K Shigeura T Matsumoto D Sato T Takaki Y Aiba-Kojima E et al. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J. Cell. Physiol. 2006;208(1):64\u201376. https:\/\/doi.org\/10.1002\/jcp.20636.","DOI":"10.1002\/jcp.20636"},{"key":"2351_CR16","doi-asserted-by":"publisher","unstructured":"Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal\/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15(6):641\u20138. https:\/\/doi.org\/10.1016\/j.jcyt.2013.02.006.","DOI":"10.1016\/j.jcyt.2013.02.006"},{"key":"2351_CR17","doi-asserted-by":"publisher","unstructured":"Mateo A Perez de la Lastra J Moreno A Dusinsky R Bilka F Simon M et al. Biochemical characterization of antigens detected with anti-platelet monoclonal antibodies. Vet. Immunol. Immunopathol. 1996;52(4):363\u201370. https:\/\/doi.org\/10.1016\/0165-2427(96)05588-2.","DOI":"10.1016\/0165-2427(96)05588-2"},{"issue":"8","key":"2351_CR18","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/ijms18081406","volume":"18","author":"SLS Ding","year":"2017","unstructured":"Ding SLS Kumar S Mok PL. Cellular reparative mechanisms of mesenchymal stem cells for retinal diseases. Int. J. Mol. Sci. 2017;18(8):1406. https:\/\/doi.org\/10.3390\/ijms18081406.","journal-title":"Int. J. Mol. Sci."},{"key":"2351_CR19","doi-asserted-by":"publisher","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137. https:\/\/doi.org\/10.1080\/14653240600855905.","DOI":"10.1080\/14653240600855905"},{"issue":"10","key":"2351_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109305","volume":"9","author":"B Mead","year":"2014","unstructured":"Mead B, Logan A, Berry M, Leadbeater W, Scheven BA. Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adipose-derived mesenchymal stem cells. PLoS ONE. 2014;9(10):e109305. https:\/\/doi.org\/10.1371\/journal.pone.0109305.","journal-title":"PLoS ONE."},{"key":"2351_CR21","doi-asserted-by":"publisher","unstructured":"Emre E, Y\u00fcksel N, Duruksu G, Pirhan D, Suba\u015fi C, Erman G, et al. Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model. Cytotherapy. 2015;17(5):543\u201359. https:\/\/doi.org\/10.1016\/j.jcyt.2014.12.005.","DOI":"10.1016\/j.jcyt.2014.12.005"},{"issue":"1","key":"2351_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13287-016-0394-0","volume":"7","author":"HR Hofer","year":"2016","unstructured":"Hofer HR Tuan RS. Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies. Stem Cell Res. Ther. 2016;7(1):131. https:\/\/doi.org\/10.1186\/s13287-016-0394-0.","journal-title":"Stem Cell Res. Ther."},{"issue":"11","key":"2351_CR23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.4252\/wjsc.v11.i11.957","volume":"11","author":"V Holan","year":"2019","unstructured":"Holan V Hermankova B Krulova M Zajicova A. Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal stem cells - a clue to stem cell-based therapy. World J. Stem Cells. 2019;11(11):957\u201367. https:\/\/doi.org\/10.4252\/wjsc.v11.i11.957.","journal-title":"World J. Stem Cells."},{"key":"2351_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fcell.2016.00083","volume":"4","author":"J Burrello","year":"2016","unstructured":"Burrello J Monticone S Gai C Gomez Y Kholia S Camussi G. Stem cell-derived extracellular vesicles and immune-modulation. Front. Cell Dev. Biol. 2016;4:83.","journal-title":"Front. Cell Dev. Biol."},{"key":"2351_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.exer.2015.08.016","volume":"144","author":"JC Koch","year":"2016","unstructured":"Koch JC Lingor P. The role of autophagy in axonal degeneration of the optic nerve. Exp. Eye Res. 2016;144:81\u20139. https:\/\/doi.org\/10.1016\/j.exer.2015.08.016.","journal-title":"Exp. Eye Res."},{"issue":"Suppl 2","key":"2351_CR26","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/sj.cdd.4401765","volume":"12","author":"T Yorimitsu","year":"2005","unstructured":"Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005;12(Suppl 2):1542\u201352. https:\/\/doi.org\/10.1038\/sj.cdd.4401765.","journal-title":"Cell Death Differ."},{"key":"2351_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.06.001","volume":"117","author":"Y Wang","year":"2015","unstructured":"Wang Y Huang C Zhang H Wu R. Autophagy in glaucoma: crosstalk with apoptosis and its implications. Brain Res. Bull. 2015;117:1\u20139. https:\/\/doi.org\/10.1016\/j.brainresbull.2015.06.001.","journal-title":"Brain Res. Bull."},{"issue":"2","key":"2351_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12015-010-9193-7","volume":"7","author":"B Lindroos","year":"2011","unstructured":"Lindroos B Suuronen R Miettinen S. The potential of adipose stem cells in regenerative medicine. Stem Cell Rev. Rep. 2011;7(2):269\u201391. https:\/\/doi.org\/10.1007\/s12015-010-9193-7.","journal-title":"Stem Cell Rev. Rep."},{"issue":"1","key":"2351_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13287-020-1549-6","volume":"11","author":"E \u00d6zmert","year":"2020","unstructured":"\u00d6zmert E Arslan U. Management of retinitis pigmentosa by Wharton\u2019s jelly derived mesenchymal stem cells: preliminary clinical results. Stem Cell Res. Ther. 2020;11(1):25. https:\/\/doi.org\/10.1186\/s13287-020-1549-6.","journal-title":"Stem Cell Res. Ther."},{"issue":"5","key":"2351_CR30","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00417-018-3953-5","volume":"256","author":"U Arslan","year":"2018","unstructured":"Arslan U \u00d6zmert E Demirel S \u00d6rnek F \u015eermet F. Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results. Graefes Arch. Clin. Exp. Ophthalmol. 2018;256(5):893\u2013908. https:\/\/doi.org\/10.1007\/s00417-018-3953-5.","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"2351_CR31","doi-asserted-by":"publisher","unstructured":"Kasetty MA, Hedges TR 3rd, Witkin AJ. Bilateral epiretinal membrane formation following intravitreal injections of autologous mesenchymal stem cells. Retin Cases Brief Rep. 2020. https:\/\/doi.org\/10.1097\/ICB.0000000000001032 Publish Ahead of Print.","DOI":"10.1097\/ICB.0000000000001032"},{"issue":"1","key":"2351_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13287-016-0432-y","volume":"7","author":"A Oner","year":"2016","unstructured":"Oner A Gonen ZB Sinim N Cetin M Ozkul Y. Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study. Stem Cell Res. Ther. 2016;7(1):178. https:\/\/doi.org\/10.1186\/s13287-016-0432-y.","journal-title":"Stem Cell Res. Ther."},{"key":"2351_CR33","doi-asserted-by":"publisher","first-page":"112067212097782","DOI":"10.1177\/1120672120977824","volume":"14","author":"NS Kahraman","year":"2020","unstructured":"Kahraman NS, \u00d6ner A. Umbilical cord-derived mesenchymal stem cell implantation in patients with optic atrophy. Eur J Ophthalmol. 2020;14:1120672120977824. https:\/\/doi.org\/10.1177\/1120672120977824.","journal-title":"Eur J Ophthalmol."},{"issue":"2","key":"2351_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/pharmaceutics13020288","volume":"13","author":"CR Wan","year":"2021","unstructured":"Wan CR, Muya L, Kansara V, Ciulla TA. Suprachoroidal delivery of small molecules, nanoparticles, gene and cell therapies for ocular diseases. Pharmaceutics. 2021;13(2):288. https:\/\/doi.org\/10.3390\/pharmaceutics13020288.","journal-title":"Pharmaceutics."},{"key":"2351_CR35","doi-asserted-by":"publisher","unstructured":"Hu ZL Li N Wei X Tang L Wang TH Chen XM. Neuroprotective effects of BDNF and GDNF in intravitreally transplanted mesenchymal stem cells after optic nerve crush in mice. Int. J. Ophthalmol. 2017;10(1):35\u201342. https:\/\/doi.org\/10.18240\/ijo.2017.01.06.","DOI":"10.18240\/ijo.2017.01.06"},{"issue":"2","key":"2351_CR36","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3892\/mmr.2017.8103","volume":"17","author":"X Li","year":"2018","unstructured":"Li X Zhao S Wang L. Therapeutic effect of adipose-derived stem cell transplantation on optic nerve injury in rats. Mol. Med. Rep. 2018;17(2):2529\u201334. https:\/\/doi.org\/10.3892\/mmr.2017.8103.","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"2351_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1517\/14712598.2016.1093110","volume":"16","author":"H Klassen","year":"2016","unstructured":"Klassen H. Stem cells in clinical trials for treatment of retinal degeneration. Expert Opin. Biol. Ther. 2016;16(1):7\u201314. https:\/\/doi.org\/10.1517\/14712598.2016.1093110.","journal-title":"Expert Opin. Biol. Ther."},{"key":"2351_CR38","first-page":"983","volume":"9","author":"PG Limoli","year":"2020","unstructured":"Limoli PG, Vingolo EM, Limoli C, Nebbioso M. Antioxidant and biological properties of mesenchymal cells used for therapy in retinitis pigmentosa. Antioxidants (Basel, Switzerland). 2020;9:983.","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"2351_CR39","doi-asserted-by":"publisher","unstructured":"Adak S, Magdalene D, Deshmukh S, Das D, Jaganathan BG. A review on mesenchymal stem cells for treatment of retinal diseases. Stem Cell Rev Rep. 2021. https:\/\/doi.org\/10.1007\/s12015-020-10090-x.","DOI":"10.1007\/s12015-020-10090-x"},{"key":"2351_CR40","doi-asserted-by":"publisher","unstructured":"Siqueira RC, Messias A, Messias K, Arcieri RS, Ruiz MA, Souza NF, et al. Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells. Stem Cell Res Ther. 2015;6(1):29. https:\/\/doi.org\/10.1186\/s13287-015-0020-6.","DOI":"10.1186\/s13287-015-0020-6"},{"key":"2351_CR41","doi-asserted-by":"publisher","unstructured":"Park SS, Bauer G, Abedi M, Pontow S, Panorgias A, Jonnal R, et al. Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Invest Ophthalmol Vis Sci. 2014;56(1):81\u20139. https:\/\/doi.org\/10.1167\/iovs.14-15415.","DOI":"10.1167\/iovs.14-15415"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02351-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T06:13:11Z","timestamp":1620281591000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02351-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2351"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02351-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]},"assertion":[{"value":"8 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospectively registered study was performed at the Low Vision Center in Milan between January 2015 and September 2019. The study was performed in accordance with the tenets of the 1964 Declaration of Helsinki and was approved by the ethics committee of the Institutional Review Board of the Low Vision Academy (No. 2014\/MC104, 4 October 2014). Written informed consent was obtained from all the patients prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}